nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—SLC15A2—multiple sclerosis	0.797	1	CbGaD
Trandolapril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00893	0.317	CbGpPWpGaD
Trandolapril—CES1—Phase I biotransformations, non P450—PON1—multiple sclerosis	0.00689	0.245	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—BCHE—multiple sclerosis	0.00209	0.0744	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00184	0.0652	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.0012	0.0427	CbGpPWpGaD
Trandolapril—Fosinopril—SLC15A2—multiple sclerosis	0.00111	0.135	CrCbGaD
Trandolapril—ACE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.00101	0.036	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—RRM1—multiple sclerosis	0.000973	0.0346	CbGpPWpGaD
Trandolapril—Perindopril—SLC15A2—multiple sclerosis	0.000905	0.11	CrCbGaD
Trandolapril—Spirapril—SLC15A2—multiple sclerosis	0.000895	0.109	CrCbGaD
Trandolapril—Moexipril—SLC15A2—multiple sclerosis	0.000858	0.105	CrCbGaD
Trandolapril—Quinapril—SLC15A2—multiple sclerosis	0.000798	0.0973	CrCbGaD
Trandolapril—Cilazapril—SLC15A2—multiple sclerosis	0.000798	0.0973	CrCbGaD
Trandolapril—Ramipril—SLC15A2—multiple sclerosis	0.000773	0.0942	CrCbGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000708	0.0252	CbGpPWpGaD
Trandolapril—Benazepril—SLC15A2—multiple sclerosis	0.000694	0.0847	CrCbGaD
Trandolapril—ACE—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.000584	0.0208	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—BCHE—multiple sclerosis	0.000541	0.0192	CbGpPWpGaD
Trandolapril—Perindopril—BCHE—multiple sclerosis	0.000474	0.0579	CrCbGaD
Trandolapril—ACE—peripheral nervous system—multiple sclerosis	0.000449	0.217	CbGeAlD
Trandolapril—Ramipril—BCHE—multiple sclerosis	0.000405	0.0494	CrCbGaD
Trandolapril—Nateglinide—SLC15A2—multiple sclerosis	0.0004	0.0488	CrCbGaD
Trandolapril—ACE—nerve—multiple sclerosis	0.00035	0.17	CbGeAlD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000317	0.0112	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—POMC—multiple sclerosis	0.00028	0.00993	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000258	0.00918	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00024	0.00852	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000191	0.0068	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000181	0.00642	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000168	0.00596	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—MYC—multiple sclerosis	0.000167	0.00593	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000161	0.00572	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PABPC1—multiple sclerosis	0.000155	0.0055	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPL5—multiple sclerosis	0.00014	0.00496	CbGpPWpGaD
Trandolapril—Oedema—Triamcinolone—multiple sclerosis	0.000134	0.000815	CcSEcCtD
Trandolapril—Vertigo—Betamethasone—multiple sclerosis	0.000134	0.000814	CcSEcCtD
Trandolapril—Vertigo—Dexamethasone—multiple sclerosis	0.000134	0.000814	CcSEcCtD
Trandolapril—Syncope—Betamethasone—multiple sclerosis	0.000134	0.000813	CcSEcCtD
Trandolapril—Syncope—Dexamethasone—multiple sclerosis	0.000134	0.000813	CcSEcCtD
Trandolapril—Arrhythmia—Prednisone—multiple sclerosis	0.000133	0.00081	CcSEcCtD
Trandolapril—Infection—Triamcinolone—multiple sclerosis	0.000133	0.00081	CcSEcCtD
Trandolapril—Sweating—Methotrexate—multiple sclerosis	0.000133	0.000809	CcSEcCtD
Trandolapril—Infection—Methylprednisolone—multiple sclerosis	0.000133	0.000808	CcSEcCtD
Trandolapril—Shock—Triamcinolone—multiple sclerosis	0.000132	0.000802	CcSEcCtD
Trandolapril—Insomnia—Prednisolone—multiple sclerosis	0.000132	0.000802	CcSEcCtD
Trandolapril—Alopecia—Prednisone—multiple sclerosis	0.000132	0.000801	CcSEcCtD
Trandolapril—Shock—Methylprednisolone—multiple sclerosis	0.000132	0.0008	CcSEcCtD
Trandolapril—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000131	0.000798	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000131	0.00467	CbGpPWpGaD
Trandolapril—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000131	0.000798	CcSEcCtD
Trandolapril—Loss of consciousness—Betamethasone—multiple sclerosis	0.000131	0.000797	CcSEcCtD
Trandolapril—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000131	0.000797	CcSEcCtD
Trandolapril—Epistaxis—Methotrexate—multiple sclerosis	0.000131	0.000796	CcSEcCtD
Trandolapril—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000131	0.000796	CcSEcCtD
Trandolapril—Paraesthesia—Prednisolone—multiple sclerosis	0.000131	0.000796	CcSEcCtD
Trandolapril—Tachycardia—Triamcinolone—multiple sclerosis	0.000131	0.000796	CcSEcCtD
Trandolapril—Mental disorder—Prednisone—multiple sclerosis	0.000131	0.000794	CcSEcCtD
Trandolapril—Nausea—Azathioprine—multiple sclerosis	0.000131	0.000794	CcSEcCtD
Trandolapril—Tachycardia—Methylprednisolone—multiple sclerosis	0.000131	0.000794	CcSEcCtD
Trandolapril—Skin disorder—Methylprednisolone—multiple sclerosis	0.00013	0.00079	CcSEcCtD
Trandolapril—Malnutrition—Prednisone—multiple sclerosis	0.00013	0.000789	CcSEcCtD
Trandolapril—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00013	0.000788	CcSEcCtD
Trandolapril—Agranulocytosis—Methotrexate—multiple sclerosis	0.00013	0.000788	CcSEcCtD
Trandolapril—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000129	0.000786	CcSEcCtD
Trandolapril—Asthenia—Mitoxantrone—multiple sclerosis	0.000128	0.000775	CcSEcCtD
Trandolapril—Myalgia—Betamethasone—multiple sclerosis	0.000127	0.000772	CcSEcCtD
Trandolapril—Myalgia—Dexamethasone—multiple sclerosis	0.000127	0.000772	CcSEcCtD
Trandolapril—Anxiety—Betamethasone—multiple sclerosis	0.000127	0.000769	CcSEcCtD
Trandolapril—Anxiety—Dexamethasone—multiple sclerosis	0.000127	0.000769	CcSEcCtD
Trandolapril—SLC15A2—retina—multiple sclerosis	0.000126	0.0612	CbGeAlD
Trandolapril—Discomfort—Dexamethasone—multiple sclerosis	0.000125	0.000762	CcSEcCtD
Trandolapril—Discomfort—Betamethasone—multiple sclerosis	0.000125	0.000762	CcSEcCtD
Trandolapril—Hypotension—Methylprednisolone—multiple sclerosis	0.000125	0.00076	CcSEcCtD
Trandolapril—Hepatitis—Methotrexate—multiple sclerosis	0.000125	0.000758	CcSEcCtD
Trandolapril—Pharyngitis—Methotrexate—multiple sclerosis	0.000124	0.000752	CcSEcCtD
Trandolapril—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000123	0.000748	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—multiple sclerosis	0.000122	0.000743	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000122	0.000743	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000122	0.000741	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000122	0.00433	CbGpPWpGaD
Trandolapril—Oedema—Betamethasone—multiple sclerosis	0.000122	0.00074	CcSEcCtD
Trandolapril—Oedema—Dexamethasone—multiple sclerosis	0.000122	0.00074	CcSEcCtD
Trandolapril—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000122	0.000739	CcSEcCtD
Trandolapril—Insomnia—Triamcinolone—multiple sclerosis	0.000121	0.000737	CcSEcCtD
Trandolapril—Insomnia—Methylprednisolone—multiple sclerosis	0.000121	0.000736	CcSEcCtD
Trandolapril—Infection—Dexamethasone—multiple sclerosis	0.000121	0.000735	CcSEcCtD
Trandolapril—Infection—Betamethasone—multiple sclerosis	0.000121	0.000735	CcSEcCtD
Trandolapril—Ill-defined disorder—Prednisone—multiple sclerosis	0.000121	0.000732	CcSEcCtD
Trandolapril—Paraesthesia—Triamcinolone—multiple sclerosis	0.00012	0.000732	CcSEcCtD
Trandolapril—Feeling abnormal—Prednisolone—multiple sclerosis	0.00012	0.000731	CcSEcCtD
Trandolapril—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00012	0.00073	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—multiple sclerosis	0.00012	0.00073	CcSEcCtD
Trandolapril—Anaemia—Prednisone—multiple sclerosis	0.00012	0.00073	CcSEcCtD
Trandolapril—Shock—Betamethasone—multiple sclerosis	0.00012	0.000728	CcSEcCtD
Trandolapril—Shock—Dexamethasone—multiple sclerosis	0.00012	0.000728	CcSEcCtD
Trandolapril—Dyspnoea—Triamcinolone—multiple sclerosis	0.00012	0.000727	CcSEcCtD
Trandolapril—Nervous system disorder—Betamethasone—multiple sclerosis	0.000119	0.000725	CcSEcCtD
Trandolapril—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000119	0.000725	CcSEcCtD
Trandolapril—Agitation—Prednisone—multiple sclerosis	0.000119	0.000725	CcSEcCtD
Trandolapril—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000119	0.000724	CcSEcCtD
Trandolapril—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000119	0.000724	CcSEcCtD
Trandolapril—Tachycardia—Betamethasone—multiple sclerosis	0.000119	0.000722	CcSEcCtD
Trandolapril—Tachycardia—Dexamethasone—multiple sclerosis	0.000119	0.000722	CcSEcCtD
Trandolapril—Angioedema—Prednisone—multiple sclerosis	0.000119	0.000721	CcSEcCtD
Trandolapril—CES1—nervous system—multiple sclerosis	0.000118	0.0573	CbGeAlD
Trandolapril—Dyspepsia—Triamcinolone—multiple sclerosis	0.000118	0.000718	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—multiple sclerosis	0.000118	0.000716	CcSEcCtD
Trandolapril—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000118	0.000716	CcSEcCtD
Trandolapril—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000118	0.000715	CcSEcCtD
Trandolapril—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000118	0.000715	CcSEcCtD
Trandolapril—Malaise—Prednisone—multiple sclerosis	0.000117	0.000712	CcSEcCtD
Trandolapril—Vertigo—Prednisone—multiple sclerosis	0.000117	0.000709	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—multiple sclerosis	0.000117	0.000708	CcSEcCtD
Trandolapril—Syncope—Prednisone—multiple sclerosis	0.000117	0.000708	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—multiple sclerosis	0.000116	0.000707	CcSEcCtD
Trandolapril—Anorexia—Dexamethasone—multiple sclerosis	0.000116	0.000705	CcSEcCtD
Trandolapril—Anorexia—Betamethasone—multiple sclerosis	0.000116	0.000705	CcSEcCtD
Trandolapril—Urticaria—Prednisolone—multiple sclerosis	0.000116	0.000704	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—multiple sclerosis	0.000116	0.000703	CcSEcCtD
Trandolapril—Fatigue—Triamcinolone—multiple sclerosis	0.000116	0.000703	CcSEcCtD
Trandolapril—Fatigue—Methylprednisolone—multiple sclerosis	0.000115	0.000701	CcSEcCtD
Trandolapril—Loss of consciousness—Prednisone—multiple sclerosis	0.000114	0.000694	CcSEcCtD
Trandolapril—CES1—central nervous system—multiple sclerosis	0.000114	0.0552	CbGeAlD
Trandolapril—Hypotension—Betamethasone—multiple sclerosis	0.000114	0.000691	CcSEcCtD
Trandolapril—Hypotension—Dexamethasone—multiple sclerosis	0.000114	0.000691	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—multiple sclerosis	0.000113	0.000688	CcSEcCtD
Trandolapril—Vomiting—Mitoxantrone—multiple sclerosis	0.000113	0.000687	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—multiple sclerosis	0.000113	0.000684	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000112	0.000683	CcSEcCtD
Trandolapril—Rash—Mitoxantrone—multiple sclerosis	0.000112	0.000681	CcSEcCtD
Trandolapril—Dermatitis—Mitoxantrone—multiple sclerosis	0.000112	0.000681	CcSEcCtD
Trandolapril—Headache—Mitoxantrone—multiple sclerosis	0.000111	0.000677	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000111	0.000674	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000111	0.000674	CcSEcCtD
Trandolapril—Arthralgia—Prednisone—multiple sclerosis	0.000111	0.000672	CcSEcCtD
Trandolapril—Myalgia—Prednisone—multiple sclerosis	0.000111	0.000672	CcSEcCtD
Trandolapril—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000111	0.000672	CcSEcCtD
Trandolapril—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00011	0.00067	CcSEcCtD
Trandolapril—Anxiety—Prednisone—multiple sclerosis	0.00011	0.00067	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—multiple sclerosis	0.00011	0.00067	CcSEcCtD
Trandolapril—Insomnia—Betamethasone—multiple sclerosis	0.00011	0.000669	CcSEcCtD
Trandolapril—Insomnia—Dexamethasone—multiple sclerosis	0.00011	0.000669	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00011	0.000667	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000109	0.000665	CcSEcCtD
Trandolapril—Paraesthesia—Dexamethasone—multiple sclerosis	0.000109	0.000664	CcSEcCtD
Trandolapril—Paraesthesia—Betamethasone—multiple sclerosis	0.000109	0.000664	CcSEcCtD
Trandolapril—Discomfort—Prednisone—multiple sclerosis	0.000109	0.000664	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—multiple sclerosis	0.000109	0.000664	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—multiple sclerosis	0.000109	0.00066	CcSEcCtD
Trandolapril—Hypersensitivity—Prednisolone—multiple sclerosis	0.000108	0.000653	CcSEcCtD
Trandolapril—Dyspepsia—Betamethasone—multiple sclerosis	0.000107	0.000651	CcSEcCtD
Trandolapril—Dyspepsia—Dexamethasone—multiple sclerosis	0.000107	0.000651	CcSEcCtD
Trandolapril—Urticaria—Triamcinolone—multiple sclerosis	0.000107	0.000648	CcSEcCtD
Trandolapril—Urticaria—Methylprednisolone—multiple sclerosis	0.000106	0.000646	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—multiple sclerosis	0.000106	0.000646	CcSEcCtD
Trandolapril—Body temperature increased—Triamcinolone—multiple sclerosis	0.000106	0.000644	CcSEcCtD
Trandolapril—Oedema—Prednisone—multiple sclerosis	0.000106	0.000644	CcSEcCtD
Trandolapril—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000106	0.000643	CcSEcCtD
Trandolapril—Decreased appetite—Dexamethasone—multiple sclerosis	0.000106	0.000643	CcSEcCtD
Trandolapril—Decreased appetite—Betamethasone—multiple sclerosis	0.000106	0.000643	CcSEcCtD
Trandolapril—Nausea—Mitoxantrone—multiple sclerosis	0.000106	0.000642	CcSEcCtD
Trandolapril—Infection—Prednisone—multiple sclerosis	0.000105	0.00064	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000105	0.000639	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000105	0.000639	CcSEcCtD
Trandolapril—Back pain—Methotrexate—multiple sclerosis	0.000105	0.000638	CcSEcCtD
Trandolapril—Fatigue—Betamethasone—multiple sclerosis	0.000105	0.000638	CcSEcCtD
Trandolapril—Fatigue—Dexamethasone—multiple sclerosis	0.000105	0.000638	CcSEcCtD
Trandolapril—Shock—Prednisone—multiple sclerosis	0.000104	0.000634	CcSEcCtD
Trandolapril—Nervous system disorder—Prednisone—multiple sclerosis	0.000104	0.000632	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000104	0.00369	CbGpPWpGaD
Trandolapril—Tachycardia—Prednisone—multiple sclerosis	0.000103	0.000629	CcSEcCtD
Trandolapril—Skin disorder—Prednisone—multiple sclerosis	0.000103	0.000626	CcSEcCtD
Trandolapril—Hyperhidrosis—Prednisone—multiple sclerosis	0.000103	0.000623	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—BCHE—multiple sclerosis	0.000102	0.00363	CbGpPWpGaD
Trandolapril—Anorexia—Prednisone—multiple sclerosis	0.000101	0.000614	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000101	0.000612	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—multiple sclerosis	0.0001	0.00061	CcSEcCtD
Trandolapril—Feeling abnormal—Dexamethasone—multiple sclerosis	0.0001	0.00061	CcSEcCtD
Trandolapril—Feeling abnormal—Betamethasone—multiple sclerosis	0.0001	0.00061	CcSEcCtD
Trandolapril—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.96e-05	0.000605	CcSEcCtD
Trandolapril—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.96e-05	0.000605	CcSEcCtD
Trandolapril—Hypersensitivity—Triamcinolone—multiple sclerosis	9.89e-05	0.000601	CcSEcCtD
Trandolapril—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.86e-05	0.000599	CcSEcCtD
Trandolapril—Malaise—Methotrexate—multiple sclerosis	9.79e-05	0.000595	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—multiple sclerosis	9.76e-05	0.000593	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—multiple sclerosis	9.72e-05	0.00059	CcSEcCtD
Trandolapril—Urticaria—Betamethasone—multiple sclerosis	9.67e-05	0.000588	CcSEcCtD
Trandolapril—Urticaria—Dexamethasone—multiple sclerosis	9.67e-05	0.000588	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.66e-05	0.000587	CcSEcCtD
Trandolapril—Dizziness—Prednisolone—multiple sclerosis	9.65e-05	0.000586	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.64e-05	0.00342	CbGpPWpGaD
Trandolapril—Asthenia—Triamcinolone—multiple sclerosis	9.63e-05	0.000585	CcSEcCtD
Trandolapril—Abdominal pain—Betamethasone—multiple sclerosis	9.62e-05	0.000585	CcSEcCtD
Trandolapril—Abdominal pain—Dexamethasone—multiple sclerosis	9.62e-05	0.000585	CcSEcCtD
Trandolapril—Body temperature increased—Dexamethasone—multiple sclerosis	9.62e-05	0.000585	CcSEcCtD
Trandolapril—Body temperature increased—Betamethasone—multiple sclerosis	9.62e-05	0.000585	CcSEcCtD
Trandolapril—Asthenia—Methylprednisolone—multiple sclerosis	9.61e-05	0.000584	CcSEcCtD
Trandolapril—Insomnia—Prednisone—multiple sclerosis	9.59e-05	0.000583	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—TGFB1—multiple sclerosis	9.56e-05	0.0034	CbGpPWpGaD
Trandolapril—Paraesthesia—Prednisone—multiple sclerosis	9.52e-05	0.000578	CcSEcCtD
Trandolapril—Pruritus—Triamcinolone—multiple sclerosis	9.49e-05	0.000577	CcSEcCtD
Trandolapril—Cough—Methotrexate—multiple sclerosis	9.47e-05	0.000576	CcSEcCtD
Trandolapril—Pruritus—Methylprednisolone—multiple sclerosis	9.47e-05	0.000575	CcSEcCtD
Trandolapril—ACE—spinal cord—multiple sclerosis	9.34e-05	0.0452	CbGeAlD
Trandolapril—Dyspepsia—Prednisone—multiple sclerosis	9.33e-05	0.000567	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—multiple sclerosis	9.24e-05	0.000562	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—multiple sclerosis	9.24e-05	0.000562	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—multiple sclerosis	9.24e-05	0.000562	CcSEcCtD
Trandolapril—Decreased appetite—Prednisone—multiple sclerosis	9.22e-05	0.00056	CcSEcCtD
Trandolapril—Rash—Prednisolone—multiple sclerosis	9.2e-05	0.000559	CcSEcCtD
Trandolapril—Dermatitis—Prednisolone—multiple sclerosis	9.19e-05	0.000558	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.18e-05	0.000558	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.18e-05	0.00326	CbGpPWpGaD
Trandolapril—Diarrhoea—Methylprednisolone—multiple sclerosis	9.16e-05	0.000557	CcSEcCtD
Trandolapril—Fatigue—Prednisone—multiple sclerosis	9.14e-05	0.000555	CcSEcCtD
Trandolapril—Headache—Prednisolone—multiple sclerosis	9.14e-05	0.000555	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—multiple sclerosis	9.13e-05	0.000555	CcSEcCtD
Trandolapril—SLC15A2—medulla oblongata—multiple sclerosis	9.13e-05	0.0442	CbGeAlD
Trandolapril—Constipation—Prednisone—multiple sclerosis	9.07e-05	0.000551	CcSEcCtD
Trandolapril—CES1—brain—multiple sclerosis	9.04e-05	0.0438	CbGeAlD
Trandolapril—Dizziness—Triamcinolone—multiple sclerosis	8.87e-05	0.000539	CcSEcCtD
Trandolapril—Dizziness—Methylprednisolone—multiple sclerosis	8.85e-05	0.000538	CcSEcCtD
Trandolapril—Infection—Methotrexate—multiple sclerosis	8.8e-05	0.000535	CcSEcCtD
Trandolapril—Feeling abnormal—Prednisone—multiple sclerosis	8.74e-05	0.000531	CcSEcCtD
Trandolapril—Asthenia—Dexamethasone—multiple sclerosis	8.74e-05	0.000531	CcSEcCtD
Trandolapril—Asthenia—Betamethasone—multiple sclerosis	8.74e-05	0.000531	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—multiple sclerosis	8.69e-05	0.000528	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—multiple sclerosis	8.68e-05	0.000527	CcSEcCtD
Trandolapril—Gastrointestinal pain—Prednisone—multiple sclerosis	8.67e-05	0.000527	CcSEcCtD
Trandolapril—Nausea—Prednisolone—multiple sclerosis	8.67e-05	0.000527	CcSEcCtD
Trandolapril—Pruritus—Betamethasone—multiple sclerosis	8.61e-05	0.000523	CcSEcCtD
Trandolapril—Pruritus—Dexamethasone—multiple sclerosis	8.61e-05	0.000523	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—multiple sclerosis	8.61e-05	0.000523	CcSEcCtD
Trandolapril—Nateglinide—ALB—multiple sclerosis	8.6e-05	0.0105	CrCbGaD
Trandolapril—Hyperhidrosis—Methotrexate—multiple sclerosis	8.57e-05	0.00052	CcSEcCtD
Trandolapril—Vomiting—Triamcinolone—multiple sclerosis	8.53e-05	0.000518	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.52e-05	0.00303	CbGpPWpGaD
Trandolapril—Vomiting—Methylprednisolone—multiple sclerosis	8.51e-05	0.000517	CcSEcCtD
Trandolapril—Rash—Triamcinolone—multiple sclerosis	8.46e-05	0.000514	CcSEcCtD
Trandolapril—Dermatitis—Triamcinolone—multiple sclerosis	8.45e-05	0.000514	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—multiple sclerosis	8.45e-05	0.000513	CcSEcCtD
Trandolapril—Rash—Methylprednisolone—multiple sclerosis	8.44e-05	0.000513	CcSEcCtD
Trandolapril—Dermatitis—Methylprednisolone—multiple sclerosis	8.43e-05	0.000512	CcSEcCtD
Trandolapril—Urticaria—Prednisone—multiple sclerosis	8.42e-05	0.000512	CcSEcCtD
Trandolapril—Headache—Triamcinolone—multiple sclerosis	8.41e-05	0.000511	CcSEcCtD
Trandolapril—Headache—Methylprednisolone—multiple sclerosis	8.39e-05	0.00051	CcSEcCtD
Trandolapril—Body temperature increased—Prednisone—multiple sclerosis	8.38e-05	0.000509	CcSEcCtD
Trandolapril—Abdominal pain—Prednisone—multiple sclerosis	8.38e-05	0.000509	CcSEcCtD
Trandolapril—SLC15A2—midbrain—multiple sclerosis	8.35e-05	0.0404	CbGeAlD
Trandolapril—Diarrhoea—Dexamethasone—multiple sclerosis	8.33e-05	0.000506	CcSEcCtD
Trandolapril—Diarrhoea—Betamethasone—multiple sclerosis	8.33e-05	0.000506	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—multiple sclerosis	8.28e-05	0.000503	CcSEcCtD
Trandolapril—SLC15A2—spinal cord—multiple sclerosis	8.14e-05	0.0395	CbGeAlD
Trandolapril—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.07e-05	0.00049	CcSEcCtD
Trandolapril—Dizziness—Dexamethasone—multiple sclerosis	8.05e-05	0.000489	CcSEcCtD
Trandolapril—Dizziness—Betamethasone—multiple sclerosis	8.05e-05	0.000489	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—multiple sclerosis	8.01e-05	0.000487	CcSEcCtD
Trandolapril—Nausea—Triamcinolone—multiple sclerosis	7.97e-05	0.000484	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—multiple sclerosis	7.96e-05	0.000483	CcSEcCtD
Trandolapril—Nausea—Methylprednisolone—multiple sclerosis	7.95e-05	0.000483	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—multiple sclerosis	7.9e-05	0.00048	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—multiple sclerosis	7.88e-05	0.000479	CcSEcCtD
Trandolapril—ACE—nervous system—multiple sclerosis	7.87e-05	0.0381	CbGeAlD
Trandolapril—Hypersensitivity—Prednisone—multiple sclerosis	7.81e-05	0.000475	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—multiple sclerosis	7.8e-05	0.000474	CcSEcCtD
Trandolapril—Vomiting—Betamethasone—multiple sclerosis	7.74e-05	0.00047	CcSEcCtD
Trandolapril—Vomiting—Dexamethasone—multiple sclerosis	7.74e-05	0.00047	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—multiple sclerosis	7.7e-05	0.000468	CcSEcCtD
Trandolapril—Rash—Betamethasone—multiple sclerosis	7.68e-05	0.000466	CcSEcCtD
Trandolapril—Rash—Dexamethasone—multiple sclerosis	7.68e-05	0.000466	CcSEcCtD
Trandolapril—Dermatitis—Betamethasone—multiple sclerosis	7.67e-05	0.000466	CcSEcCtD
Trandolapril—Dermatitis—Dexamethasone—multiple sclerosis	7.67e-05	0.000466	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.65e-05	0.000465	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—multiple sclerosis	7.64e-05	0.000464	CcSEcCtD
Trandolapril—Headache—Dexamethasone—multiple sclerosis	7.63e-05	0.000463	CcSEcCtD
Trandolapril—Headache—Betamethasone—multiple sclerosis	7.63e-05	0.000463	CcSEcCtD
Trandolapril—Asthenia—Prednisone—multiple sclerosis	7.61e-05	0.000462	CcSEcCtD
Trandolapril—ACE—central nervous system—multiple sclerosis	7.58e-05	0.0367	CbGeAlD
Trandolapril—Pruritus—Prednisone—multiple sclerosis	7.5e-05	0.000456	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—multiple sclerosis	7.3e-05	0.000444	CcSEcCtD
Trandolapril—Diarrhoea—Prednisone—multiple sclerosis	7.25e-05	0.000441	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.25e-05	0.00044	CcSEcCtD
Trandolapril—Nausea—Dexamethasone—multiple sclerosis	7.23e-05	0.000439	CcSEcCtD
Trandolapril—Nausea—Betamethasone—multiple sclerosis	7.23e-05	0.000439	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—multiple sclerosis	7.04e-05	0.000428	CcSEcCtD
Trandolapril—Dizziness—Prednisone—multiple sclerosis	7.01e-05	0.000426	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—multiple sclerosis	7.01e-05	0.000426	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—multiple sclerosis	7.01e-05	0.000426	CcSEcCtD
Trandolapril—SLC15A2—nervous system—multiple sclerosis	6.86e-05	0.0332	CbGeAlD
Trandolapril—Vomiting—Prednisone—multiple sclerosis	6.74e-05	0.00041	CcSEcCtD
Trandolapril—Rash—Prednisone—multiple sclerosis	6.69e-05	0.000406	CcSEcCtD
Trandolapril—Dermatitis—Prednisone—multiple sclerosis	6.68e-05	0.000406	CcSEcCtD
Trandolapril—Headache—Prednisone—multiple sclerosis	6.64e-05	0.000404	CcSEcCtD
Trandolapril—SLC15A2—central nervous system—multiple sclerosis	6.61e-05	0.032	CbGeAlD
Trandolapril—Hypersensitivity—Methotrexate—multiple sclerosis	6.53e-05	0.000397	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.5e-05	0.00231	CbGpPWpGaD
Trandolapril—SLC15A2—cerebellum—multiple sclerosis	6.46e-05	0.0313	CbGeAlD
Trandolapril—Asthenia—Methotrexate—multiple sclerosis	6.36e-05	0.000386	CcSEcCtD
Trandolapril—Nausea—Prednisone—multiple sclerosis	6.3e-05	0.000383	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—multiple sclerosis	6.27e-05	0.000381	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—multiple sclerosis	6.06e-05	0.000368	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.04e-05	0.00214	CbGpPWpGaD
Trandolapril—ACE—brain—multiple sclerosis	6.01e-05	0.0291	CbGeAlD
Trandolapril—Dizziness—Methotrexate—multiple sclerosis	5.86e-05	0.000356	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—multiple sclerosis	5.63e-05	0.000342	CcSEcCtD
Trandolapril—Rash—Methotrexate—multiple sclerosis	5.59e-05	0.000339	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—multiple sclerosis	5.58e-05	0.000339	CcSEcCtD
Trandolapril—Headache—Methotrexate—multiple sclerosis	5.55e-05	0.000337	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—POMC—multiple sclerosis	5.28e-05	0.00188	CbGpPWpGaD
Trandolapril—Nausea—Methotrexate—multiple sclerosis	5.26e-05	0.00032	CcSEcCtD
Trandolapril—SLC15A2—brain—multiple sclerosis	5.24e-05	0.0254	CbGeAlD
Trandolapril—ACE—Metabolism of proteins—CCL2—multiple sclerosis	5.16e-05	0.00183	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.3e-05	0.00117	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.07e-05	0.00109	CbGpPWpGaD
